NCT06295562View on ClinicalTrials.gov

Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

PHASE4RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Obstructive Sleep Apnea of Adult
Interventions
DRUG

Atomoxetine 80mg combined with oxybutynin 5mg

Atomoxetine 80mg combined with oxybutynin 5mg

DRUG

Venlafaxine 37.5mg

Venlafaxine 37.5mg

DRUG

Atomoxetine 80mg combined with trazodone 100mg

Atomoxetine 80mg combined with trazodone 100mg

DRUG

Placebo

Placebo tablet

Trial Locations (1)

Unknown

RECRUITING

China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER